Treatment for Osteoarthritis (U-Propel Trial)

N/A

Waitlist Available

Research Sponsored by United Orthopedic Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

The purpose of this study is to evaluate both short and long term clinical performance and safety of the commercially available U2 Knee™ System.

Eligible Conditions

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Implant Survivorship

Secondary study objectives

Change in EQ-5D Over Time

Change in EQ-5D VAS Over Time

Change in KOOS, JR. Over Time

+4 more

Do I qualify?Apply below to find out

United Orthopedic CorporationLead Sponsor

3 Previous Clinical Trials

270 Total Patients Enrolled

1 Trials studying Osteoarthritis

200 Patients Enrolled for Osteoarthritis

~24 spots leftby Sep 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.